In the latest trading session,, 1.46 million Elevance Health Inc (NYSE:ELV) shares changed hands as the company’s beta touched 0.61. With the company’s most recent per share price at $359.42 changed hands at -$36.34 or -9.18% at last look, the market valuation stands at $81.21B. ELV’s current price is a discount, trading about -57.83% off its 52-week high of $567.26. The share price had its 52-week low at $357.45, which suggests the last value was 0.55% up since then. When we look at Elevance Health Inc’s average trading volume, we note the 10-day average is 1.57 million shares, with the 3-month average coming to 1.79 million.
Analysts gave the Elevance Health Inc (ELV) stock a consensus recommendation rating of Buy, calculated at a mean rating of 1.70. If we narrow down to specifics, the data shows that 0 out of 12 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 1 recommended ELV as a Hold, 11 felt it is a Buy and 0 rated the stock as Underweight. Elevance Health Inc’s EPS for the current quarter is expected to be 9.19.
Elevance Health Inc (NYSE:ELV) trade information
Instantly ELV was in red as seen in intraday trades today. With action -3.86%, the performance over the past five days has been red. The company’s shares are showing year-to-date downside of -33.67%, with the 5-day performance at -3.86% in the red. However, in the 30-day time frame, Elevance Health Inc (NYSE:ELV) is -4.67% down. Looking at the short shares, we see there were 2.5 million shares sold at short interest cover period of 1.29 days.
The consensus price target for the stock as assigned by Wall Street analysts is 482.5, meaning bulls need an upside of 25.51% from its recent market value. According to analyst projections, ELV’s forecast low is 465 with 500 as the target high. To hit the forecast high, the stock’s price needs a -39.11% plunge from its current level, while the stock would need to soar -29.38% for it to hit the projected low.
Elevance Health Inc (ELV) estimates and forecasts
Year-over-year growth is forecast to reach 10.95% up from the last financial year.
Consensus estimates given by 11 financial analysts project the company’s revenue in the current quarter to hit an average of 48.26B. 11 analysts are of the opinion that Elevance Health Inc’s revenue for the current quarter will be 48.68B. The company’s revenue for the corresponding quarters a year ago was 43.22B and 44.72B respectively. According to analysts, the company will likely register a growth in its current quarter sales, forecast at 11.65%. The estimates for the next quarter sales put growth at 8.86%.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of 6.81%. The 2025 estimates are for Elevance Health Inc earnings to increase by 4.36%, but the outlook for the next 5-year period is at 10.60% per year.
ELV Dividends
Elevance Health Inc is expected to release its next quarterly earnings report on 2025-Apr-22. The 1.86% annual yield figure for the share gives it an annual dividend of 6.68. It is important to note, however, that the 1.86% dividend yield ratio should serve as a guide only, as you should also take into consideration many other aspects of a company’s operations and fundamentals before making any investment decision. During the past 5 years, the average dividend yield was 1.2 per year.
Elevance Health Inc (NYSE:ELV)’s Major holders
If we look at who the major shareholders are, we find that insiders hold 0.17% of Elevance Health Inc shares while 93.07% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 93.23%. There are 93.07% institutions holding the Elevance Health Inc stock share, with VANGUARD GROUP INC the top institutional holder. As of 2024-06-30, the company held 9.133% of the shares, roughly 21.21 million ELV shares worth $11.49 billion.
BLACKROCK INC. holds the second largest percentage of outstanding shares, with 8.9168% or 20.7 million shares worth $11.22 billion as of 2024-06-30.
Among Mutual Funds, the top two as of Mar 31, 2025 were VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund and VANGUARD INDEX FUNDS-Vanguard 500 Index Fund . With 7.06 shares estimated at $2.58 billion under it, the former controlled 3.12% of total outstanding shares. On the other hand, VANGUARD INDEX FUNDS-Vanguard 500 Index Fund held about 2.80% of the shares, roughly 6.32 shares worth around $2.31 billion.
